Cytosine Arabinoside and Mitoxantrone Followed by Second Allogeneic Transplant for the Treatment of Children With Refractory Juvenile Myelomonocytic Leukemia

Hematopoietic stem cell transplantation (HSCT) remains the only curative option for most patients with juvenile myelomonocytic leukemia (JMML). However, persistent disease and relapse rates after transplant range from 26% to 58%. We report the successful use of second HSCT after preparation with mit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Patel, Sachit A., Coulter, Don W., Grovas, Alfred C., Gordon, Bruce G., Harper, James L., Warkentin, Phyllis I., Wisecarver, James L., Sanger, Warren G., Coccia, Peter F.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2014
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4048652/
https://ncbi.nlm.nih.gov/pubmed/24322499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPH.0000000000000077
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados